[go: up one dir, main page]

RS51687B - Kristalni oblici 4-[2-4-(4-metilfenilsulfanil)fenil]piperidina sa kombinovanom inhibicijom reapsorpcije serotonina i norepinefrina za lečenje neuropatskog bola - Google Patents

Kristalni oblici 4-[2-4-(4-metilfenilsulfanil)fenil]piperidina sa kombinovanom inhibicijom reapsorpcije serotonina i norepinefrina za lečenje neuropatskog bola

Info

Publication number
RS51687B
RS51687B RS20110223A RSP20110223A RS51687B RS 51687 B RS51687 B RS 51687B RS 20110223 A RS20110223 A RS 20110223A RS P20110223 A RSP20110223 A RS P20110223A RS 51687 B RS51687 B RS 51687B
Authority
RS
Serbia
Prior art keywords
pain
compound
treatment
addition salt
depression
Prior art date
Application number
RS20110223A
Other languages
English (en)
Serbian (sr)
Inventor
Benny Bang-Andersen
André FALDT
Tine Bryan STENSBÖL
Silke Miller
Heidi Lopez De Diego
Original Assignee
H. Lundbeck A/S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S. filed Critical H. Lundbeck A/S.
Publication of RS51687B publication Critical patent/RS51687B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4465Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/08Malonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/12Glutaric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08Lactic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
RS20110223A 2006-06-16 2007-06-15 Kristalni oblici 4-[2-4-(4-metilfenilsulfanil)fenil]piperidina sa kombinovanom inhibicijom reapsorpcije serotonina i norepinefrina za lečenje neuropatskog bola RS51687B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80500906P 2006-06-16 2006-06-16
DKPA200600816 2006-06-16
DKPA200700423 2007-03-20

Publications (1)

Publication Number Publication Date
RS51687B true RS51687B (sr) 2011-10-31

Family

ID=39722478

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20110223A RS51687B (sr) 2006-06-16 2007-06-15 Kristalni oblici 4-[2-4-(4-metilfenilsulfanil)fenil]piperidina sa kombinovanom inhibicijom reapsorpcije serotonina i norepinefrina za lečenje neuropatskog bola

Country Status (15)

Country Link
JP (1) JP2014098017A (zh)
KR (1) KR101472595B1 (zh)
AR (1) AR061480A1 (zh)
AT (1) ATE508115T1 (zh)
BR (1) BRPI0712758A2 (zh)
CA (1) CA2784304A1 (zh)
DE (1) DE602007014372D1 (zh)
DK (1) DK2044020T3 (zh)
MY (1) MY150698A (zh)
NZ (1) NZ572856A (zh)
PT (1) PT2044020E (zh)
RS (1) RS51687B (zh)
SI (1) SI2044020T1 (zh)
TN (1) TNSN08461A1 (zh)
TW (1) TWI444365B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101972931B1 (ko) 2017-10-19 2019-04-26 재단법인대구경북과학기술원 풍선 타입 피질전도 측정장치 및 이의 제조방법
CN116930385B (zh) * 2023-08-08 2024-02-20 北京爱思益普生物科技股份有限公司 一种高盐浓度制剂中化合物浓度的测定方法
CN117305360B (zh) * 2023-09-15 2024-09-24 江南大学 一种哺乳动物细胞核转染液及其制备方法和在细胞核内递送的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
HRP20110412T1 (hr) * 2006-06-16 2011-06-30 H. Lundbeck A/S Kristalni oblici 4-[2-4-(4-metilfenilsulfanil)fenil]piperidina sa kombiniranom inhibicijom reapsorpcije serotonina i norepinefrina za liječenje neuropatskih bolova

Also Published As

Publication number Publication date
DK2044020T3 (da) 2011-08-15
MY150698A (en) 2014-02-28
ATE508115T1 (de) 2011-05-15
TWI444365B (zh) 2014-07-11
BRPI0712758A2 (pt) 2012-09-25
TNSN08461A1 (en) 2010-04-14
KR20090018630A (ko) 2009-02-20
AR061480A1 (es) 2008-08-27
PT2044020E (pt) 2011-05-12
DE602007014372D1 (de) 2011-06-16
JP2014098017A (ja) 2014-05-29
CA2784304A1 (en) 2007-12-21
TW200817329A (en) 2008-04-16
NZ572856A (en) 2012-02-24
KR101472595B1 (ko) 2014-12-15
SI2044020T1 (sl) 2011-06-30

Similar Documents

Publication Publication Date Title
EP2044020B1 (en) Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
KR101536023B1 (ko) 조합된 sert, 5-ht3 및 5-ht1a 활성을 가진 화합물의 치료 용도
EP2139479B1 (en) 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
KR20100092956A (ko) 세로토닌 수송체, 세로토닌 수용체 및 노드아드레날린 수송체에 친화성을 갖는 화합물의 치료 용도
AU2008228637B2 (en) Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine
RS51687B (sr) Kristalni oblici 4-[2-4-(4-metilfenilsulfanil)fenil]piperidina sa kombinovanom inhibicijom reapsorpcije serotonina i norepinefrina za lečenje neuropatskog bola
CN101472891B (zh) 有神经病痛治疗用血清素和去甲肾上腺素再摄取综合抑制作用的4-[2-(4-甲基苯硫基)苯基]哌啶的结晶形式
HK1134287B (zh) 有神经病痛治疗用血清素和去甲肾上腺素再摄取综合抑制作用的4-[2-(4-甲基苯硫基)苯基]哌啶的结晶形式
HK1142007B (zh) 有adhd,忧郁症,治疗抵抗的抑郁症或抑郁症的残留症状治疗用血清素和去甲肾上腺素再摄取综合抑制作用的4-[2-(4-甲基苯硫基)苯基]哌啶